Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

[21-1326] U.S. ex rel. Schutte v. SuperValu Inc.

[21-1326] U.S. ex rel. Schutte v. SuperValu Inc.

FromSupreme Court Oral Arguments


[21-1326] U.S. ex rel. Schutte v. SuperValu Inc.

FromSupreme Court Oral Arguments

ratings:
Length:
72 minutes
Released:
Apr 18, 2023
Format:
Podcast episode

Description

U.S. ex rel. Schutte v. SuperValu Inc.
Justia (with opinion) · Docket · oyez.org
Argued on Apr 18, 2023.Decided on Jun 1, 2023.
Petitioner: Unites States of America, Ex. Rel. Schutte, et al..Respondent: SuperValu Inc., et al..
Advocates: Tejinder Singh (for the Petitioners)
Malcolm L. Stewart (for the United States, as amicus curiae, supporting the Petitioners)
Carter G. Phillips (for the Respondents)
Facts of the case (from oyez.org)
SuperValu owned or operated approximately 2,500 grocery stories with over 800 in-store pharmacies between 2006 and 2016. To compete with other pharmacies, SuperValu stores implemented a prescription price-matching program, under which it would match lower prescription prices of competitors. However, SuperValu did not report its price-match program prices as its usual and customary price, in violation of Medicaid regulations.
Tracy Schutte and Michael Yarberry (the “Relators”) sued SuperValu under the False Claims Act on behalf of the federal government and several states. They alleged that SuperValu knowingly caused false payment claims to be submitted to government healthcare programs between 2006 and 2016 by incorrectly reporting their drug prices. The federal government did not intervene in the case.
The district court concluded that the Relators had failed to prove the “scienter” element of their FCA claim—that is, they failed to show SuperValu that SuperValu’s interpretation of the reporting requirement was objectively unreasonable at the time. The U.S. Court of Appeals for the Seventh Circuit affirmed.

Question
Is a defendant’s contemporaneous subjective understanding about the lawfulness of its conduct relevant to whether it “knowingly” violated the False Claims Act?

Conclusion
The False Claims Act’s scienter element refers to a defendant’s knowledge and subjective beliefs, not to what an objectively reasonable person may have known or believed. Justice Clarence Thomas authored the opinion for a unanimous Court.
Both the text and common-law origins of the False Claims Act support an understanding of the scienter as focusing on the subjective knowledge of the defendant. It describes a three-part definition of the word “knowingly” that largely tracks the common-law concept of scienter for fraud: actual knowledge, deliberate indifference, or recklessness. Each of these concepts pertains to the defendant’s lack of an honest belief in the statement’s truth when making the claim, not what a defendant might have thought afterward.
Released:
Apr 18, 2023
Format:
Podcast episode

Titles in the series (100)

A podcast feed of the audio recordings of the oral arguments at the U.S. Supreme Court. * Podcast adds new arguments automatically and immediately after they become available on supremecourt.gov * Detailed episode descriptions with facts about the case from oyez.org and links to docket and other information. * Convenient chapters to skip to any exchange between a justice and an advocate (available as soon as oyez.org publishes the transcript). Also available in video form at https://www.youtube.com/@SCOTUSOralArgument